ArticleEnvironmental health and preventive medicine2026
Helicobacter pylori infection, atrophic gastritis, and disabling dementia: the Japan Public Health Center-based Prospective Study.
Article in Environmental health and preventive medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundA meta-analysis reported a positive association between Helicobacter pylori (H. pylori) infection and dementia incidence. H. pylori infection leads to atrophic gastritis (AG) and affects the absorption of nutrients needed for nerve growth, such as vitamin B12 and folate. We aimed to clarify the associations of H. pylori IgG titer, AG, and their combination with disabling dementia incidence and to examine the interaction with vitamin B12 and folate.
methodsAnti-H. pylori immunoglobulin G (IgG) titer and pepsinogen levels were measured in 6,817 participants in 1993 (40-69 years), and the incidence of disabling dementia was followed during a median follow-up of 11.0 years. Associations of anti-H. pylori IgG titer, AG, and their combination with disabling dementia were examined using a multivariable-adjusted Cox proportional hazard model, with stratified analyses by dietary intake of vitamin B12 and folate.
results1,325 (19.4%) developed disabling dementia during the follow-up period from 2006 to 2016. Among participants with low vitamin B12 intake, H. pylori infection and severe AG were positively associated with the risk of disabling dementia, with HRs of 1.26 (95% CI: 1.01-1.58) for H. pylori infection (H. pylori IgG titer ≥10 U/mL) and 1.34 (95% CI: 1.06-1.68) for severe AG. Additionally, having both H. pylori infection and AG was associated with an increased risk of dementia among individuals consuming less vitamin B12 than the median (HR 1.30, 95% CI: 1.05-1.61), compared with H. pylori-seronegative and AG-negative.
conclusionsThe combination of H. pylori infection, subsequent AG, and low vitamin B12 intake may be related to increased risk of dementia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.